- Home
- DERM
as 04-18-2025 1:34pm EST
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | SCOTTSDALE |
| Market Cap: | 140.0M | IPO Year: | 2021 |
| Target Price: | $10.00 | AVG Volume (30 days): | 103.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.20 - $7.29 | Next Earning Date: | 05-12-2025 |
| Revenue: | $56,134,000 | Revenue Growth: | -29.11% |
| Revenue Growth (this year): | 29.83% | Revenue Growth (next year): | 54.88% |
Stock Insider Trading Activity of Journey Medical Corporation (DERM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Maraoui Claude | DERM | President & CEO | Mar 11 '25 | Sell | $5.01 | 49,271 | $246,847.71 | 2,003,147 | |
| Maraoui Claude | DERM | President & CEO | Mar 6 '25 | Sell | $5.03 | 40,456 | $203,451.09 | 2,003,147 | |
| Maraoui Claude | DERM | President & CEO | Mar 3 '25 | Sell | $5.12 | 70,556 | $360,761.67 | 2,003,147 | |
| Benesch Joseph | DERM | CFO | Feb 21 '25 | Sell | $5.19 | 1,365 | $7,084.35 | 45,966 |
Latest Journey Medical Corporation News
DERM Breaking Stock News: Dive into DERM Ticker-Specific Updates for Smart Investing
Zacks
12 days ago
Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains?
MT Newswires
18 days ago
Journey Medical Promotes Ramsey Alloush to COO
GlobeNewswire
18 days ago
Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer
Simply Wall St.
22 days ago
Journey Medical Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Thomson Reuters StreetEvents
23 days ago
Q4 2024 Journey Medical Corp Earnings Call
GuruFocus.com
23 days ago
Journey Medical Corp (DERM) Q4 2024 Earnings Call Highlights: Strategic Launch of Emrosi and ...
Zacks
24 days ago
Journey Medical Corporation (DERM) Tops Q4 Earnings Estimates
GlobeNewswire
24 days ago
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
Compare DERM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DERM Journey Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.